Serum follistatin is increased in thyroid cancer and is associated with adverse tumor characteristics in humans. Panagiotou G, Ghaly W, Upadhyay J, Pazaitou-Panayiotou K, et al. J Clin Endocrinol Metab 2021 Jan 25. pii: 6119546. doi: 10.1210.

Read + Share

Amedeo Smart

Independent Medical Education

Panagiotou G, Ghaly W, Upadhyay J, Pazaitou-Panayiotou K, et al. Serum follistatin is increased in thyroid cancer and is associated with adverse tumor characteristics in humans. J Clin Endocrinol Metab 2021 Jan 25. pii: 6119546. doi: 10.1210.
PMID: 33493282